{"product_id":"erlonib_erlotinib","title":"Erlonib (Erlotinib)","description":"\u003cp\u003eErlotinib is an oral tyrosine kinase inhibitor (TKI) that targets the epidermal growth factor receptor (EGFR). By blocking EGFR signaling, it prevents tumor cell proliferation, survival, and metastasis. It is a targeted cancer therapy, not traditional chemotherapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-start=\"403\" data-end=\"436\"\u003e\u003cstrong data-start=\"407\" data-end=\"434\"\u003eMain Uses\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"439\" data-end=\"480\"\u003eNon-Small Cell Lung Cancer (NSCLC):\n\u003cul\u003e\n\u003cli data-start=\"485\" data-end=\"609\"\u003eFirst-line treatment in patients with EGFR mutation–positive tumors (exon 19 deletions or exon 21 L858R substitution).\u003c\/li\u003e\n\u003cli data-start=\"614\" data-end=\"723\"\u003eTreatment of locally advanced or metastatic NSCLC after failure of at least one prior chemotherapy regimen.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"726\" data-end=\"750\"\u003ePancreatic cancer:\n\u003cul\u003e\n\u003cli data-start=\"755\" data-end=\"856\"\u003eUsed in combination with gemcitabine for locally advanced, unresectable, or metastatic disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp data-start=\"863\" data-end=\"890\"\u003e\u003cstrong data-start=\"867\" data-end=\"888\"\u003eContraindications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"893\" data-end=\"965\"\u003eHypersensitivity to erlotinib or any component of the formulation.\u003c\/li\u003e\n\u003cli data-start=\"968\" data-end=\"1023\"\u003ePregnancy and breastfeeding (risk of fetal harm).\u003c\/li\u003e\n\u003cli data-start=\"1026\" data-end=\"1053\"\u003eCaution in patients with:\n\u003cul\u003e\n\u003cli data-start=\"1058\" data-end=\"1114\"\u003eSevere liver impairment (hepatotoxicity possible).\u003c\/li\u003e\n\u003cli data-start=\"1119\" data-end=\"1216\"\u003eHistory of interstitial lung disease (ILD) (rare but potentially fatal pulmonary toxicity).\u003c\/li\u003e\n\u003cli data-start=\"1221\" data-end=\"1287\"\u003eSevere gastrointestinal conditions (risk of GI perforation).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage: \u003c\/strong\u003eThe dosage of this medicine depends on the prescription and instruction given by the doctor.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautions: \u003c\/strong\u003eDo not take this medicine without any medical consultation with your doctor.\u003c\/p\u003e","brand":"Camber Pharmaceutical Inc","offers":[{"title":"Tablet (150 mg) in Box of 30's","offer_id":47317541191909,"sku":"202507201651","price":45000.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/4681\/1877\/files\/79e2d9_7fdfb001a44744699e39852548685ae4_mv2.avif?v=1759341651","url":"https:\/\/thogpharmacyco.com\/products\/erlonib_erlotinib","provider":"THOG Pharmacy Co","version":"1.0","type":"link"}